Tech Healthcare Sector

Targeted Medical Pharma

Market Cap: US$29.0

A specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States.

Medivolve

Market Cap: US$27.0

A principal investment firm.

Neurobiological Technologies

Market Cap: US$27.0

Operates under a plan of liquidation and dissolution approved by stockholders in October 2009.

Lombard Medical

Market Cap: US$27.0

A medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally.

FluoroPharma Medical

Market Cap: US$27.0

A biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States.

DiaSys

Market Cap: US$25.0

Designs, develops, manufactures, and distributes proprietary medical laboratory equipment, consumables, and test kits to healthcare and veterinary diagnostic laboratories worldwide.

TetraLogic Pharmaceuticals

Market Cap: US$24.0

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases.

VMT Scientific

Market Cap: US$24.0

Engages in the design, development, testing, and patenting of medical technologies for use in tissue histogenesis.

Verde Science

Market Cap: US$23.0

A pharmaceutical research and development company, focuses on developing a portfolio of cannabinoid based prescription medicines for various medical conditions.

Regnum

Market Cap: US$22.0

Develops and commercializes therapeutics that treat rare and infectious diseases.

BC Craft Supply

Market Cap: US$22.0

Engages in development and acquisition of nutritional product formulae and cannabinoid brands.

Corix Bioscience

Market Cap: US$20.0

Provides cannabidiol (CBD) oil for various medicinal purposes.

VIA Pharmaceuticals

Market Cap: US$20.0

A development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases.

Korver

Market Cap: US$17.0

Engages in the design and manufacture of integrated machine controls that are sold to manufacturers of plastic parts for the automotive, household products, and electronics industries worldwide.

Xcorporeal

Market Cap: US$15.0

Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010.

Tibet Pharmaceuticals

Market Cap: US$14.0

A specialty pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Tibetan medicines.

PhaseRx

Market Cap: US$11.0

A biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy.

American Medical Technologies

Market Cap: US$10.0

Develops, manufactures, and markets dental related equipment.

Easy Technologies

Market Cap: US$10.0

Develops an Internet based platform in the online gaming area.

Vasamed

Market Cap: US$8.0

Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States.

Turbine Aviation

Market Cap: US$8.0

A development stage company, through its subsidiary, H7 Security Systems, Inc., develops and markets homeland security products.

Innoveren Scientific

Market Cap: US$8.0

A medical bioscience company that develops technology in regenerative medicine for limb salvage.

Proteonomix

Market Cap: US$7.0

A biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives.

Bionovate Technologies

Market Cap: US$7.0

A medical device company, focuses on developing automated treatment for age spots.

VioQuest Pharmaceuticals

Market Cap: US$6.0

VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases.

Stem Holdings

Market Cap: US$6.0

Does not have significant operations.

Excellerant

Market Cap: US$5.0

A development stage company, focuses on providing a range of health advisory and tour services to legal entities and individuals.

Rosetta Genomics

Market Cap: US$5.0

Operates as a genomic diagnostics company worldwide.

Speedus

Market Cap: US$4.0

Through its subsidiaries, engages in the development of diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists, and other healthcare professionals in the United States.

Arch Therapeutics

Market Cap: US$4.0

Operates as a biotechnology company.

Acusphere

Market Cap: US$4.0

Operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs.

Nabriva Therapeutics

Market Cap: US$3.0

A biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections.

Synvista Therapeutics

Market Cap: US$2.0

A product-based biopharmaceutical company, develops diagnostic tests and drugs to identify and treat diabetic patients at high risk for the development of cardiovascular disease.

Heart Tronics

Market Cap: US$0

A medical device company, engages in the research, development, and marketing of medical devices in the United States.

Rennova Health

Market Cap: US$0

Provides health care services in the United States.

G-H-3 International

Market Cap: US$0

Develops products for addressing factors, which cause aging and deterioration in the body.